Navigation Links
Veran Medical Technologies Announces Initial Shipment of SPiN Drive® Platform to Customers
Date:1/17/2012

ST. LOUIS, Jan. 17, 2012 /PRNewswire/ -- Veran Medical Technologies announced today that the Company has started initial shipments of its SPiN Drive® electromagnetic navigation platform, an advanced solution that biopsies peripheral Solitary Pulmonary Nodules (SPNs) for the potential early diagnosis of lung cancer. 

The SPiN Drive system design may improve efficiency and enhance workflow by allowing the physician to never lose or remove navigation at the time of biopsy with the Always-On Tip Tracked™ instruments. The platform is the first in electromagnetic navigation to provide optimal facility flexibility by requiring no unique bed or room calibration.  Additionally, the ability to view airways during procedures may provide a significant advantage toward targeting SPNs.

Targets are viewed on high-resolution CT images using a patient-specific view, without any radiation being delivered to the patient, physician or staff.  In addition, the SPiN Drive technology includes bi-planar virtual fluoroscopy view used to navigate multiple planes simultaneously.  This advancement is the first of its kind in pulmonology, enabling physicians to view the location of the Always-On Tip Tracked instrument. 

"The SPiN Drive platform is ground-breaking technology in electromagnetic navigation," said Gregg Smith, vice president of sales and marketing at Veran Medical Technologies.  "The SPiN Drive system has generated tremendous market excitement since its introduction.  As expected, hospitals looking to provide the most advanced electromagnetic navigation technology for early diagnosis of lung cancer are seeking the SPiN Drive platform.  We are excited about the interest in SPiN Drive and believe we are strongly positioned for growth in 2012."  

Lung cancer is a deadly disease that mortally claims 85 percent of patients within five years. According to the recent NLST (National Lung Screen Trial) study, there is a 21 percent reduction in mortality for patients screened for lung cancer.  Many SPNs in the peripheral lung are inaccessible with today's techniques and technologies, leaving patients on "watchful waiting" protocols of repeat CT scanning causing significant patient anxiety and unproductive costs added to the U.S. Healthcare System.  Veran's SPiN Drive product acts as a GPS-like system to enable pulmonologists and surgeons to access SPNs, aid in obtaining biopsy tissue for diagnosis and end watchful waiting. 

About Veran Medical Technologies, Inc. Veran Medical Technologies is a privately held company led by a team of innovators focused on developing the next standard of care for minimally invasive delivery of interventional oncology therapies.  Veran has built several clinical products upon its ig4™ platform technology, which uses proprietary 4D registration capabilities for targeting lesions within the human body.  The company believes that by enabling minimally invasive early stage diagnosis, it can increase patient survival and lower healthcare costs significantly.  Veran Medical Technologies is headquartered in St. Louis, MO.

 

 


'/>"/>
SOURCE Veran Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Veran Medical Technologies Launches New SPiN Drive™ Application for Bi-Planar Virtual Fluoroscopy View
2. Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System
3. VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System
4. Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy
5. The Market Outlook for Refurbished Medical Devices to 2016
6. Terumo Americas Holding Acquires Onset Medical Corporation, a Leader in Innovative Sheath Technology Designed for Multiple, Minimally Invasive Clinical Applications
7. Public Policy Staffing Study Offers Benchmark Opportunity for Bio-Pharma and Medical Device Companies
8. Arriva Medical Acquires Direct Diabetic Source
9. Aethlon Medical Establishes Sepsis & Inflammation Scientific Advisory Board
10. Simbionix Comprehensive Medical Simulators now Available in Additional Languages
11. Suneva Medical to Pursue Expanded Indications for Artefill® With Launch of Phase III Acne Scar Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Australien, 24. Februar 2017 ITL ... Unternehmen des Gesundheitsbereiches, ist erfreut, für das zum ... dem entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu können. ... Aktualisierung zum Wachstum" finden Sie hier . ... Gewinn nach Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
(Date:2/24/2017)... 2017  Directors from Pharma To Market Pty Ltd and Ador ... resulting in the founding of Pharma To Market Pte Ltd, based ... are pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia ... Singapore based entity. Joelle brings with her an ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing ... B2B Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads based ... of IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the sales ...
(Date:2/26/2017)... ... 2017 , ... ODH, Inc.™ announced today it will exhibit and speak ... City Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will ... Medicaid population health management. , ODH will also have an exhibit booth where attendees ...
(Date:2/26/2017)... ... 2017 , ... Occupational pesticide exposure is linked to an ... according to a study released today at the 1st Pan American Parkinson’s and ... pesticides and incidence of sporadic PD through occupational exposure. This latest study, led ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, expert ... Core benefits and advantages built into the home office sit stand solution are ... feel. Ability to gain the benefits embedded in the TaskMate Go are available ...
(Date:2/24/2017)... ... ... two months after the official release of The Private Collection – Edition 2017 at ... a second print-run of its lavish luxury travel coffee table book. , An ... at more than six kilos, retails at EUR 1,000 per copy and is packed ...
Breaking Medicine News(10 mins):